Skip to Content
Skip to Main Navigation
Skip to Local Navigation
Skip to Search

Muscletech Hydroxystim 3s, 18s, 110s and 200s capsules

Medicine recall

30 October 2012

Retailers and consumers are advised that, after consultation with the TGA, all available batches of Muscletech Hydroxystim capsules (AUST L 187422) have been recalled by the sponsor, Export Corporation (Australia) Pty Ltd trading as Nutrition Systems. Muscletech Hydroxystim capsules are marketed as a complementary medicine for use by body builders.

An analysis of some Muscletech Hydroxystim capsules identified the presence of a banned chemical-1.3-dimethylamylamine (DMAA). DMAA is a toxic substance with potentially dangerous side effects. The sale, supply and use of DMAA was prohibited by state and territory law this year.

The batch numbers are:

• 0102J1 (3-capsule sample pack)
• 0209K1 (18-capsule pack)
• 0210K1 (110-capsule pack)
• 0211K1 (200-capsule pack)

The batch number is displayed on the bottom of the product's bottle and on the side of the 3-capsule sample pack. The expiry date for these batches is 9 November 2013.

Information for consumers

If you have Muscletech Hydroxystim capsules stop taking them immediately and return them to the place of purchase for a refund, or call Muscletech's customer service line on 1300 883 523. Among the reasons DMAA has been banned are:

• it has no health benefits and is a toxic substance
• risks associated with its use include high blood pressure, psychiatric disorders, bleeding in the brain and stroke
• its long-term safety has not been demonstrated
• it presents a high risk of abuse, misuse and illicit use.

If you have taken Muscletech Hydroxystim capsules and are concerned about your health, you should contact your health professional.

Additional information

Nutrition Systems is contacting retailers and distributors in Australia regarding collection of recalled stock. Those businesses are being asked to check their stock and cease the sale, distribution and/or sampling of Muscletech Hydroxystim capsules, effective immediately. They are also being asked to quarantine all such products.

Reporting problems

Consumers and health professionals are encouraged to report problems with medicines. Your report will contribute to our monitoring of medicines.

The TGA cannot give personal advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine, vaccine or medical device.

Top of page